您的位置: 首页 > 农业专利 > 详情页

Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
专利权人:
Atopix Therapeutics Limited
发明人:
Payton, Mark Anthony,Pettipher, Eric Roy
申请号:
AU2012351342
公开号:
AU2012351342A1
申请日:
2012.12.14
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
Disclosed are methods and compositions for preventing, treating, or ameliorating eosinophilic esophagitis (EoE) in an individual, comprising administering to the individual a therapeutically effective amount of at least one CRTH2 antagonist or a pharmaceutically acceptable salt thereof and at least one proton pump inhibitor (PPI) or a pharmaceutically acceptable salt thereof. Also disclosed are compositions comprising at least one CRTH2 antagonist or a phannaceutically acceptable salt thereof and at least one proton pump inhibitor or a pharmaceutically acceptable salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充